SCHEMBL30456687

SCHEMBL30456687

COC(=O)C(N)c1cccc(Br)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 2/20 0.43
IDO1 P14902 1/20 0.42
TDO2 P48775 1/20 0.42
MAPT P10636 2/20 0.42
POLB P06746 1/20 0.42
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
PARP1 P09874 1/20 0.41
TSHR P16473 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP1A2 P05177 1/20 0.40
GAA P10253 1/20 0.40
RECQL P46063 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.39
CASP3 P42574 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SENP8 Q96LD8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17764345 1.00 KMT2A (0.44) KMT2AALDH1A1IDO1TDO2MAPT
SCHEMBL3652623 1.00 KMT2A (0.44) KMT2AALDH1A1IDO1TDO2MAPT
SCHEMBL3895480 0.88 KMT2A (0.52) KMT2AALDH1A1PTGS1PTGS2TSHR
SCHEMBL26684921 0.83 KMT2A (0.53) KMT2AALDH1A1IDO1TDO2MAPT
SCHEMBL31570147 0.83 KMT2A (0.53) KMT2AALDH1A1IDO1TDO2MAPT
SCHEMBL3655233 0.83 KMT2A (0.47) KMT2AALDH1A1IDO1TDO2MAPT
Hydrochloric Acid SCHEMBL7524403 0.83 MMP8 (0.43) ALDH1A1IDO1TDO2MAPTPARP1
SCHEMBL4366704 0.81 ADRB1 (0.50) KMT2AALDH1A1POLBPTGS1PTGS2
SCHEMBL1133808 0.81 PTGS1 (0.60) KMT2AALDH1A1MAPTPOLBPTGS1
SCHEMBL14624428 0.81 PTGS1 (0.60) KMT2AALDH1A1MAPTPOLBPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4551566-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS Les Laboratoires Servier (FR) 2025-05-14 EP disclosed
EP-4448508-A1 BENZOTHIOPHENE DERIVATIVES AS RXFP1 AGONISTS Bristol-Myers Squibb Company (US) 2024-10-23 EP disclosed
WO-2024008941-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS LES LABORATOIRES SERVIER (FR) 2024-01-11 WO disclosed
WO-2023114823-A1 BENZOTHIOPHENE DERIVATIVES AS RXFP1 AGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-06-22 WO disclosed